Purple Biotech Reaches Recommended Phase 2 Dose for NT219

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to Purple Biotech Reaches Recommended Phase 2 Dose for NT219
(NASDAQ: PPBT) Delayed: 4.78 -0.08 (1.65%)
Previous Close $4.86    52 Week High $ 
Open $4.96    52 Week Low $ 
Day High $5.13    P/E N/A 
Day Low $4.70    EPS $ 
Volume 11,342       

(NASDAQ: PPBT) Delayed: 4.78 -0.08 (1.65%)
Previous Close $4.86    52 Week High $ 
Open $4.96    52 Week Low $ 
Day High $5.13    P/E N/A 
Day Low $4.70    EPS $ 
Volume 11,342